Natsume A - Search Results

1

Chromatin regulator PRC2 is a key regulator of epigenetic plasticity in glioblastoma.

Natsume A, Ito M, Katsushima K, Ohka F, Hatanaka A, Shinjo K, Sato S, Takahashi S, Ishikawa Y, Takeuchi I, Shimogawa H, Uesugi M, Okano H, Kim SU, Wakabayashi T, Issa JP, Sekido Y, Kondo Y. Natsume A, et al. Cancer Res. 2013 Jul 15;73(14):4559-70. doi: 10.1158/0008-5472.CAN-13-0109. Epub 2013 May 29. Cancer Res. 2013. PMID: 23720055

2

Intraventricular chordoid meningioma presenting with Castleman disease due to overproduction of interleukin-6. Case report.

Arima T, Natsume A, Hatano H, Nakahara N, Fujita M, Ishii D, Wakabayashi T, Doyu M, Nagasaka T, Yoshida J. Arima T, et al. Among authors: natsume a. J Neurosurg. 2005 Apr;102(4):733-7. doi: 10.3171/jns.2005.102.4.0733. J Neurosurg. 2005. PMID: 15871519

3

IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide.

Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J. Natsume A, et al. Cancer Res. 2005 Sep 1;65(17):7573-9. doi: 10.1158/0008-5472.CAN-05-0036. Cancer Res. 2005. PMID: 16140920

4

Brain metastases from apocrine carcinoma of the scalp: case report.

Shimato S, Wakabayashi T, Mizuno M, Nakahara N, Hatano H, Natsume A, Ishii D, Hasegawa Y, Hyodo I, Nagasaka T, Yoshida J. Shimato S, et al. Among authors: natsume a. J Neurooncol. 2006 May;77(3):285-9. doi: 10.1007/s11060-005-9039-3. Epub 2005 Nov 29. J Neurooncol. 2006. PMID: 16314948

5

EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinib.

Shimato S, Mitsudomi T, Kosaka T, Yatabe Y, Wakabayashi T, Mizuno M, Nakahara N, Hatano H, Natsume A, Ishii D, Yoshida J. Shimato S, et al. Among authors: natsume a. Neuro Oncol. 2006 Apr;8(2):137-44. doi: 10.1215/15228517-2005-002. Epub 2006 Jan 20. Neuro Oncol. 2006. PMID: 16510849 Free PMC article.

6

[Glioma].

Wakabayashi T, Natsume A, Yoshida J. Wakabayashi T, et al. Among authors: natsume a. Nihon Rinsho. 2006 Jul;64(7):1327-32. Nihon Rinsho. 2006. PMID: 16838652 Review. Japanese.

7

A combination of IFN-beta and temozolomide in human glioma xenograft models: implication of p53-mediated MGMT downregulation.

Natsume A, Wakabayashi T, Ishii D, Maruta H, Fujii M, Shimato S, Ito M, Yoshida J. Natsume A, et al. Cancer Chemother Pharmacol. 2008 Apr;61(4):653-9. doi: 10.1007/s00280-007-0520-x. Epub 2007 Jun 13. Cancer Chemother Pharmacol. 2008. PMID: 17564708

8

Inhibition of Aurora-B function increases formation of multinucleated cells in p53 gene deficient cells and enhances anti-tumor effect of temozolomide in human glioma cells.

Tsuno T, Natsume A, Katsumata S, Mizuno M, Fujita M, Osawa H, Nakahara N, Wakabayashi T, Satoh Y, Inagaki M, Yoshida J. Tsuno T, et al. Among authors: natsume a. J Neurooncol. 2007 Jul;83(3):249-58. doi: 10.1007/s11060-007-9335-1. Epub 2007 Feb 14. J Neurooncol. 2007. PMID: 17570035

9

Genetically heterogeneous glioblastoma recurring with disappearance of 1p/19q losses: case report.

Ito M, Wakabayashi T, Natsume A, Hatano H, Fujii M, Yoshida J. Ito M, et al. Among authors: natsume a. Neurosurgery. 2007 Jul;61(1):E168-9; discussion E169. doi: 10.1227/01.neu.0000279739.53425.5c. Neurosurgery. 2007. PMID: 17621007

10

Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.

Nakane Y, Natsume A, Wakabayashi T, Oi S, Ito M, Inao S, Saito K, Yoshida J. Nakane Y, et al. Among authors: natsume a. J Neurosurg. 2007 Aug;107(2):398-404. doi: 10.3171/JNS-07/08/0398. J Neurosurg. 2007. PMID: 17695396

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters